Event Videos

http://www.ncbi.nlm.nih.gov/pubmed/24843060

Middleman AB, Baker CJ, Kozinetz CA, Kamili S, Nguyen C, Hu DJ, Spradling PR. Duration of protection after infant hepatitis B vaccination series. Pediatrics.2014 Jun; 133(6): e1500-7.

Abstract

BACKGROUND:
Little is known about duration of protection after the infant primary series of hepatitis B (HB) vaccine in settings of low HB endemicity. This study sought to determine the proportion of adolescents immunized as infants who had protective titers of antibody to hepatitis B surface antigen (anti-HBs) before and after a challenge dose of vaccine.

METHODS:

Published on: 
Jun-2014

http://www.ncbi.nlm.nih.gov/pubmed/24288032

Amatya P, Shah D, Gupta N, Bhatta NK. Clinical and ultrasonographic measurement of liver size in normal children. Indian J Pediatr. 2014 May; 81(5):441-5.
Abstract
OBJECTIVES:

To measure the normal range of dimensions of liver in children of various age groups and to compare the liver measurement obtained by palpation-percussion, auscultation and ultrasonography.
METHODS:

Published on: 
May-2014

http://www.ncbi.nlm.nih.gov/pubmed/24509302

Mandal S, Miraglia R, Maruzzelli L, Liotta R, Tuzzolino F, Spada M, Riva S, Luca A. US guided percutaneous liver biopsy in pediatric liver transplant recipients. J Pediatr Gastroenterol Nutr. 2014 Jun; 58(6): 756-61.

Abstract

OBJECTIVES:
The present study assesses the safety of ultrasound (US)-guided percutaneous liver biopsies (PLBs) within pediatric liver allograft recipients, describes the pathological results according to early (≤12 months) and late (>12 months) post transplantation periods, and analyses the value of liver function tests (LFTs) and Doppler US variables in determining these results.

METHODS:

Published on: 
Jun-2014

http://www.ncbi.nlm.nih.gov/pubmed/23884647

Alam S, Khanna R, Mukund A. Clinical and prothrombotic profile of hepatic vein outflow tract obstruction. Indian J Pediatr. 2014 May; 81(5):434-40.

Abstract
OBJECTIVE:

To study the clinical as well as prothrombotic profile and outcome of hepatic venous outflow tract obstruction in children
METHODS:

This is a prospective st.udy of a cohort of hepatic venous outflow tract obstruction (HVOTO) pediatric cases. All children and adolescents presenting with acute or chronic liver disease were screened for HVOTO with ultrasound and Doppler imaging and confirmed by multi-detector computerised tomography (MDCT) with contrast enhancement.
RESULTS:

Published on: 
May-2014

http://www.ncbi.nlm.nih.gov/pubmed/24552673

Tutar O, Beşer ÖF, Adaletli I, Tunc N, Gulcu D, Kantarci F, Mihmanli I, Cokugras FC, Kutlu T, Ozbay G, Erkan T. Shear wave elastography in the evaluation of liver fibrosis in children. J Pediatr Gastroenterol Nutr. 2014 Jun; 58(6): 750-5.

Abstract

BACKGROUND:
Shear-wave elastography (SWE) is a novel non-invasive method that involves application of local mechanical compression on soft tissue using focused ultrasonography and acquiring strain images that show tissue response. In this study, our goal was to assess the performance of SWE in the staging of liver fibrosis in children with chronic liver disease.

METHODS:

Published on: 
Jun-2014

http://www.ncbi.nlm.nih.gov/pubmed/24792633

Bakula A, Socha P, Klaudel-Dreszler M, Karolczyk G, Wozniak M, Rutynowska-Pronicka O, Matysiak M. Giant cell hepatitis with autoimmune haemolytic anemia in children: proposal for therapeutic approach. J Pediatr Gastroenterol Nutr. 2014 May; 58(5):669-73.
Abstract
BACKGROUND AND OBJECTIVE:

Giant cell hepatitis (GCH) with autoimmune hemolytic anemia (AIHA) is a rare, progressive disorder in infants and young children. The disease is aggressive and may lead to liver or multi organ failure with fatal prognosis. Therapy with anti-CD20 monoclonal antibody, rituximab (Rtx), proved effective. The primary objective of the study was to evaluate therapy for severe GCH with AIHA.
METHODS:

Published on: 
May-2014

http://www.ncbi.nlm.nih.gov/pubmed/24345826

Oʼsullivan TA, Oddy WH, Bremner AP, Sherriff JL, Ayonrinde OT, Olynyk JK,

Beilin LJ, Mori TA, Adams LA. Lower fructose intake may help protect against development of non-alcoholic Fatty liver in adolescents with obesity. J Pediatr Gastroenterol Nutr. 2014 May; 58(5): 624-31.
Abstract
OBJECTIVES:

Although obesity is a major risk factor for non-alcoholic fatty liver (NAFL), not all individuals with obesity develop the condition, suggesting that other factors such as diet may also contribute to NAFL development. We evaluated associations between fructose and total sugar intake and subsequent diagnosis of NAFL in adolescents with obesity and without obesity in a population-based cohort.
METHODS:

Published on: 
May-2014

http://www.ncbi.nlm.nih.gov/pubmed/24002804

Hsu C, Tsou HH, Lin SJ, Wang MC, Yao M, Hwang WL, Kao WY, Chiu CF, Lin SF, Lin J, Chang CS, Tien HF, Liu TW, Chen PJ, Cheng AL; Taiwan Cooperative Oncology Group. Chemotherapy-induced hepatitis B reactivation in lymphoma patients with resolved HBV infection: A prospective study. Hepatology. 2014 Jun; 59(6):2092-100.

Abstract

Published on: 
Jun-2014

http://www.ncbi.nlm.nih.gov/pubmed/24325386

Hatamkhani S, Khalili H, Karimzadeh I, Dashti-Khavidaki S, Abdollahi A, Jafari S. Carnitine for prevention of antituberculosis drug-induced hepatotoxicity: a randomized, clinical trial. J Gastroenterol Hepatol. 2014 May; 29(5):997-1004.

Abstract

BACKGROUND AND AIM:

In the present study, the potential benefits of oral carnitine in preventing antituberculosis drug-induced hepatotoxicity (ATDH) were evaluated.
METHODS:

Published on: 
May-2014

CLF Intro movie

Financial Aid Offered by Trusts

Follow us on: